China Healthcare Regulatory Affairs Outsourcing Market: How Is NMPA Reform Driving Demand for Regulatory Affairs Expertise?
China's NMPA regulatory reform creating outsourcing demand — the National Medical Products Administration's systematic modernization of China's drug and medical device approval framework — accelerating review timelines, implementing ICH (International Council for Harmonisation) technical guidelines, establishing priority review designations, and creating new clinical trial...
0 Σχόλια 0 Μοιράστηκε 398 Views 0 Προεπισκόπηση